Abstract 5612: Evaluating the cytotoxic effectiveness of a novel TCR-like bispecific T cell engager targeting the PR1/HLA-A2 leukemia antigen

Overall 5-year survival rates of myeloid leukemiapatients remain low at Citation Format: Amanda Cernosek Herrmann, Jin Seon Im, Hong He, Sergueeva Anna, Sijie Lu, Jeffrey Molldrem. Evaluating the cytotoxic effectiveness of a novel TCR-like bispecific T cell engager targeting the PR1/HLA-A2 leukemia antigen [abstract]. In: Proceedings of the American Association for Cancer ResearchAnnual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5612.